What's in Wuhan YZY Biopharma Co., Ltd.'s pipeline?

Wuhan YZY Biopharma Co., Ltd. has 11 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 9 in Phase 1.

Which companies overlap with Wuhan YZY Biopharma Co., Ltd.'s portfolio?

Top competitors by shared drug class: Allakos Inc., Allergan, Amgen, AstraZeneca, Atom Therapeutics Co., Ltd.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/wuhan-yzy-biopharma-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Wuhan YZY Biopharma Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Wuhan YZY Biopharma Co., Ltd. pipeline: 0 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 1 Phase 2 9 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
M701	M701	phase 3	Bispecific antibody		Oncology

Therapeutic area mix

Oncology · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Allakos Inc. · 1 shared drug class
Allergan · 1 shared drug class
Amgen · 1 shared drug class
AstraZeneca · 1 shared drug class
Atom Therapeutics Co., Ltd · 1 shared drug class
BioNTech SE · 1 shared drug class
Coherus Oncology, Inc. · 1 shared drug class
Air Force Military Medical University, China · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Wuhan YZY Biopharma Co., Ltd.:

Cite this brief

Drug Landscape (2026). Wuhan YZY Biopharma Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/wuhan-yzy-biopharma-co-ltd. Accessed 2026-05-18.